Summary:
Have you been diagnosed with Essential Tremor?
Sage Therapeutics is looking for qualified participants for a clinical research study of an investigational product (SAGE-217) to evaluate reduction in the severity of tremor in people living with ET
Qualified Participants Must:
• Essential tremor patients will participate in this two-part study for up to 8 weeks
Qualified Participants May Receive:
All patients in Part A will receive the study drug. Patients in Part B will be randomly assigned to one of two groups—one group will receive the study drug and the other will receive a placebo (non-active substance with no drug.)